EE562 Cost-Effectiveness and Budget Impact Analyses of Implementing the First Pillar of Patient Blood Management, With Intravenous (IV) Ferric Carboxymaltose (FCM), on the Turkish Healthcare System
| Autor: | Ramirez de Arellano Serna, A, Tatar, M, Alkis, N, Guclu, CY, Bermede, O, Erdemli, B, Gunaydin, S |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S166-S166 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect